Related by context. All words. (Click for frequent words.) 83 2 methoxyestradiol 78 oral prodrug 78 orally administered inhibitor 78 XL# anticancer compounds 77 PI3K/Akt pathway inhibitor 77 Personalized Immunotherapy 77 Panzem R NCD 77 polysaccharide polymer 76 PDE4 inhibitor 76 Archexin 76 investigational pharmacologically unique 76 targeted radiotherapeutic 76 AAG geldanamycin analog 76 PNP inhibitor 75 Genasense ® oblimersen 75 Crofelemer budesonide foam 75 CTAP# Capsules 75 acetonide FA 75 Panzem ® 75 molecular imaging radiopharmaceutical 75 SinuNase TM 75 MAGE A3 ASCI 75 INCB# [001] 75 R#/MEM # 75 GVAX ® 75 Tezampanel 75 FOLOTYN ® 75 #ME# 75 IMiDs ® 75 refractory chronic lymphocytic 75 SinuNase ™ 75 IMiDs R 74 TNF Tumor Necrosis Factor 74 Peginterferon alfa 2b 74 RhuDex ® 74 personalized cellular immunotherapy 74 candidate deforolimus 74 novel VDA molecule 74 ALN PCS 74 topically applied SEPA 74 PDX pralatrexate 74 NeuroSTAT ® 74 investigational humanized monoclonal antibody 74 selective modulator 74 TBC# 74 LymphoStat B belimumab 74 formerly LymphoStat B 74 include PLX IBD 74 non porcine pancreatic 74 ARRY # 74 R sorafenib tablets 74 Factor VIIa 73 erlotinib Tarceva ® 73 seliciclib CYC# 73 IAP inhibitor 73 non nucleoside inhibitor 73 Zorbtive TM 73 delivers fluocinolone acetonide FA 73 vapreotide acetate 73 sorafenib tablets 73 sodium Injection 73 pralatrexate injection folate analogue 73 highly selective inhibitor 73 Bezielle 73 Liprotamase 73 TRO# 73 Phase 2b Clinical Trial 73 oral picoplatin 73 JAK1 73 LibiGel ® 73 Inhalation Solution 73 thalidomide Thalomid 73 methylnaltrexone bromide 73 vidofludimus 73 Lubiprostone 73 lintuzumab SGN 73 PEGylated Fab fragment 73 oncolytic virus therapies 73 THR beta agonist 73 intranasal formulation 73 forodesine 73 liposomal formulation 73 metaglidasen 73 VEGFR2 inhibitor 73 Aflibercept 73 thetreatment 73 Phase 2a Clinical Trial 73 Empatic TM 73 RhuDex TM 73 Muraglitazar 73 HQK 73 TRANSDUR ® 73 adalimumab Humira 73 MOVIPREP R 73 volociximab 73 kidney urologic 73 Meets Primary Endpoint 73 Solazed TM 73 lucinactant 73 CD# CEA 73 lexidronam injection 73 dasatinib Sprycel ® 73 peripherally acting 72 PEG SN# 72 hyaluronidase enzyme 72 beta 1a 72 mertansine 72 Dapagliflozin 72 Xanafide 72 CYT# potent vascular disrupting 72 Zemiva TM 72 Xeloda ® 72 tiapamil 72 Presents Preclinical Data 72 Ocrelizumab 72 mGluR5 negative 72 small molecule Hedgehog 72 compound INCB# 72 ALN HPN 72 IRX 2 72 Oracea TM 72 FOLFOX6 chemotherapy regimen 72 Onconase 72 sapropterin dihydrochloride 72 MKC# MT 72 TELINTRA 72 mocetinostat MGCD# 72 evaluating picoplatin 72 docetaxel Taxotere R 72 Panzem 72 octreotide acetate 72 MTP inhibitor 72 virus HCV protease inhibitor 72 sodium glucose cotransporter 72 aripiprazole Abilify 72 Hsp# Inhibitor 72 Phase 2b Trial 72 novel histone deacetylase 72 SPRYCEL ® 72 Omacetaxine 72 markets HP Acthar 72 acyclovir Lauriad R 72 XP# XP# 72 mitogen activated ERK kinase 72 Completes Patient Enrollment 72 Initiates Enrollment 72 anticancer compound 72 Ticagrelor 72 GW# [003] 72 protein tyrosine phosphatase 1B 72 ara C 72 TPI ASM8 72 reslizumab 72 targeting Inflammatory Bowel 72 delta opioid receptor 72 Silodosin 72 Glufosfamide 72 PEGylated anti 72 cathepsin K inhibitor 72 Pegloticase 72 long acting muscarinic 72 IMPDH inhibitor 72 dihydrochloride Tablets 72 pan histone deacetylase 72 ENMD # 72 HMG CoA reductase inhibitors 72 IL# PE#QQR 72 BiovaxID TM 72 CCR9 antagonist 72 IMiDs ® compound 72 Thiarabine 72 ALN TTR 72 R Saizen R 72 somatostatin analogue 72 INSPIRE Trial Phase III 72 Phase #b/#a clinical 71 Pivotal Phase III 71 generation purine nucleoside 71 Tarceva TM 71 TRIOLEX HE# APOPTONE HE# 71 COLAZAL R 71 Xcytrin R 71 hypoxia activated prodrug 71 BENLYSTA ® 71 Vidofludimus 71 alvespimycin 71 inflammatory autoimmune diseases 71 targets Galectin receptors 71 erlotinib Tarceva R 71 PKC# 71 bucindolol hydrochloride 71 PRTX 71 vosaroxin 71 OvaRex R 71 JAK2 Inhibitor 71 Mg Usa 71 KNS # 71 selective A2A adenosine receptor 71 Androxal TM 71 xanthine oxidase inhibitor 71 PRT# 71 Traficet EN 71 HuLuc# 71 IAP inhibitors 71 R lenalidomide 71 Chemophase 71 Files IND 71 5 HT3 antagonist 71 faropenem medoxomil 71 oral isotype selective HDAC 71 ThermoDox ® clinical 71 Anturol ® 71 Tyrima 71 PANVAC VF 71 histone deacetylase HDAC inhibitor 71 YONDELIS 71 sapacitabine CYC# 71 Exherin 71 MKC# 71 pioglitazone HCl 71 Augment TM 71 Zenvia ™ 71 TRAIL receptor antibodies 71 PLK1 SNALP 71 ADP receptor antagonist 71 Perforomist ™ Inhalation Solution 71 telomerase therapeutic 71 Inhalation Aerosol 71 SNT MC# 71 MEK inhibitor 71 essential thrombocythemia ET 71 Initiates Clinical 71 dextromethorphan quinidine 71 RhuDex R 71 Leukine ® 71 phase III isavuconazole 71 PF # [002] 71 CCX# 71 Disease IBD 71 MKC# MKC# PP 71 Interferon alpha 71 TELINTRA R 71 anti amnesic 71 Aganocide 71 antibody MAb 71 TKB# 71 Receives Orphan Drug Designation 71 ELND-#/AZD-# 71 diarrhea predominant irritable 71 rxRNA 71 Serostim ® 71 evaluating tivozanib 71 dasatinib Sprycel 71 ELACYT 71 Civacir 71 CYP#A# CYP#D# 71 nasal calcitonin product 71 DNA methyltransferase inhibitors 71 BRILINTA 71 IMA# 71 Aliskiren 71 oral nucleoside analogue 71 receptor tyrosine kinase inhibitor 71 lenalidomide Revlimid R 71 CYT# vascular disrupting 71 multi kinase inhibitor 71 Talabostat 71 etanercept Enbrel 71 Empatic ™ 71 induced mucositis 71 pan HDAC inhibitor 71 norepinephrine reuptake inhibitor 71 Nexavar ® 71 Cleviprex TM clevidipine 71 Genasense R oblimersen 71 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 71 Lenocta 71 Aurora Kinase 71 BENLYSTA TM 71 rasagiline tablets 71 Apoptone 71 inhibitor PPI 71 Fludara ® 71 First Patient Dosed 71 mTOR mammalian target 71 OvaRex ® MAb 71 Investigational Treatment 71 FUSILEV ® 71 histamine dihydrochloride 71 Fx #A 71 peptidic compound 71 refractory gout 71 CRMD# 71 LymphoStat B TM 71 TLK# 71 Vandetanib 71 Initiate Clinical Trial 71 XYOTAX TM 70 proteasome inhibitor 70 candidate Gencaro TM 70 IMiDs 70 Romiplostim 70 CB2 selective receptor agonist 70 Alfacell proprietary ribonuclease 70 selective estrogen receptor modulator 70 Elagolix 70 docetaxel Taxotere ® 70 Kuvan R 70 Afatinib 70 mGluR2 NAM 70 Sudhir Agrawal D.Phil 70 histone deacetylase inhibitor 70 PEGylated interferon 70 mTOR inhibitor 70 Pathway Inhibitor 70 investigational immunotherapy 70 Interferon Beta 70 demonstrated antitumor activity 70 Entereg R 70 drug pipeline TAFA# 70 5 HT2A inverse 70 oxybutynin ATD TM 70 diabetic neuropathic pain 70 oral isoform selective HDAC 70 treat chronic sinusitis 70 targeted antifolate 70 Receives Orphan Drug 70 Soliris TM eculizumab 70 5 HT2A serotonin 70 Safinamide 70 CDK cyclin dependent 70 vaccines oncolytic virus 70 Icatibant 70 oral beclomethasone dipropionate 70 JAK inhibitor 70 Plicera 70 RELOVAIR ™ 70 next generation URAT1 70 Dyloject TM 70 R#/MEM 70 ELADUR ™ 70 developing Bicifadine serotonin 70 TKM ApoB 70 GLP1 INT TM 70 prokinetic agent 70 Bortezomib 70 Oral Calcitonin 70 Vitrasert R 70 Proxinium TM 70 Long acting beta2 70 Cloretazine 70 investigational monoclonal antibody 70 Varespladib 70 Romidepsin 70 tezampanel 70 OMNARIS HFA 70 radiation sensitizer 70 Orphan Drug designations 70 NEBIDO R 70 triggers apoptosis programmed 70 LEVADEX TM 70 cMET 70 sunitinib Sutent ® 70 Initiates Clinical Trial 70 Phase Ib IIa 70 Vicinium TM 70 tizanidine hydrochloride short 70 torezolid phosphate 70 Ceflatonin R 70 myelodysplastic myeloproliferative diseases 70 ThermoDox R 70 induced macular edema 70 urocortin 2 70 hyperphenylalaninemia HPA due 70 modified glutathione analog 70 psoriasis rheumatoid arthritis 70 SERMs 70 Voreloxin 70 Belimumab 70 ZEVALIN ® 70 Anidulafungin 70 metformin sulfonylurea 70 Sapacitabine 70 drug ISA# 70 Cloretazine ® 70 selective androgen receptor modulator 70 Marqibo TM 70 inhaled liposomal ciprofloxacin 70 Golimumab 70 CORT # 70 imatinib Gleevec ® 70 PrevOnco ™ 70 trastuzumab DM1 T DM1 70 Intravenous CP 70 Bazedoxifene 70 ABILIFY ® 70 Saxagliptin 70 REGN# 70 Panzem NCD 70 Phase Ib clinical trials 70 VISICOL R 70 MEK Inhibitor 70 Ostabolin C TM 70 Calcitonin 70 mild vasodilator 70 Kuvan sapropterin dihydrochloride 70 DDP# 70 Abiraterone acetate 70 Besivance 70 receptor partial agonist 70 R bisoprolol Euthyrox 70 novel synthetic PEGylated 70 systemic juvenile idiopathic 70 IgG1 monoclonal antibody 70 interferon gamma 1b 70 oral salmon calcitonin 70 OMP #R# 70 Pruvel TM 70 Mg Uk 70 Janus kinase 70 Nanobody 70 Gemzar ® 70 Daclizumab 70 humanized interleukin 6 70 midstage clinical 70 LEUKINE 70 Iluvien ® 70 adenosine injection 70 Ophena TM 70 TAFA# 70 R metformin Concor 70 Annamycin 70 Telik logo TELINTRA 70 miconazole Lauriad ® 70 ATL# [002] 70 RhuDex 70 ASONEP TM 70 humanized monoclonal 70 humanised monoclonal antibody 70 Evoltra ® 70 neuropathy sparing 70 TRIOLEX ™ 70 orally inhaled 70 HGS# 70 QUADRAMET R 70 HCV RNA polymerase 70 albiglutide 70 ospemifene 70 herpetic keratitis 70 rheumatoid arthritis thrombocytopenia 70 Teriflunomide 70 TRX1 70 immunomodulating 70 BAY #-# 70 Squalamine 70 proprietary polysaccharide 70 MEK inhibitors 70 Presents Preclinical 70 memantine HCl 70 Preclinical studies suggest 70 including eniluracil ADH 70 oral dihydropyrimidine dehydrogenase DPD 70 Exherin TM 70 brand ciclesonide HFA 70 Submits NDA 70 investigational antiplatelet agent 70 P#X# antagonist 70 glucagon receptor 70 carbohydrate polymer 70 VAPRISOL 70 inhaled formulation 70 Maribavir 70 orBec R oral beclomethasone 70 Initiates Phase II 70 Drug Candidate 70 Ovitrelle R Serostim 70 TOCOSOL Camptothecin 70 CDP# 70 isoform selective 70 Troxatyl 70 Pazopanib 70 selective adenosine 70 Vaccine Adjuvant 70 BXT # 70 Dosa suffers 70 apricitabine ATC 70 * olmesartan medoxomil 70 rhIGF-I/rhIGFBP-3 70 Gel repository corticotropin injection 70 OMNARIS Nasal Spray 69 Vaprisol 69 forodesine hydrochloride 69 PRN FDA Approves 69 vinca alkaloid 69 Dasatinib 69 oral dual endothelin 69 cutaneous T 69 ® lenalidomide 69 EGFR HER2 69 Orally administered 69 CEQ# 69 immunotherapeutic vaccine 69 TYZEKA 69 SILENOR TM doxepin HCl 69 Phase IIb Clinical Trial 69 corticotropin injection 69 allosteric modulator NAM 69 PORxin TM 69 ATL# [001] 69 COPEGUS R 69 markets COLAZAL 69 AVASTIN 69 product Fentanyl TAIFUN 69 Tanespimycin 69 SYN# 69 ICA # 69 systemic anaplastic large 69 Simulect 69 2 inhibitor CYT# 69 Initiate Phase 69 Vidaza azacitidine 69 BYETTA ® 69 Fodosine 69 tubulin inhibitor 69 therapeutically inactive prodrug 69 Febuxostat 69 Elotuzumab 69 novel oral anticoagulant 69 Kosan dependence 69 elotuzumab 69 NDA Submission 69 Liposomal 69 DOS# 69 oral proteasome inhibitor 69 LEP ETU 69 rNAPc2 69 Triolex 69 Aviptadil 69 Cetrorelix 69 Reports Preclinical Data 69 R roscovitine 69 thymalfasin 69 valtorcitabine 69 oral ridaforolimus 69 Syncria R 69 Campath ® 69 Cyclooxygenase Inhibiting Nitric Oxide 69 Investigational Compound 69 HDL Mimetic Peptide 69 small molecule thrombopoietin 69 Recombinant Human 69 Pafuramidine 69 IMiD 69 lomitapide 69 Dalbavancin 69 Zoraxel TM 69 Granted Orphan Drug 69 EVIZON TM squalamine lactate 69 Cardium Therapeutics TM 69 TRANSDUR ™ 69 Copegus ® 69 Ecallantide 69 targeting CD# 69 visilizumab 69 ATRA IV 69 systemic RNAi therapeutic 69 metformin HCl 69 orally administered synthetic retinoid 69 Tramiprosate ALZHEMED TM 69 Pruvel 69 Actonel risedronate 69 D aspartate NMDA receptor 69 arsenic trioxide injection 69 Dementia Related Psychosis 69 HDAC Inhibitor 69 itraconazole Sporanox 69 chemosensitizer 69 Denufosol 69 temsirolimus Torisel 69 Phase IIb Trial 69 XL# XL# XL# XL# 69 adenosine A2A 69 Phase IIb clinical trials 69 nucleoside analog 69 compound perifosine 69 DexaSite 69 lesinurad 69 relapsed leukemia 69 Amigal TM 69 5 lipoxygenase inhibitor 69 PSN# [002] 69 accumulate preferentially 69 severe hypercholesterolemia 69 Mycophenolate Mofetil 69 5 FU leucovorin 69 DCVax R 69 rALLy clinical trial 69 FUSILEV enhances 69 ZFP Therapeutics 69 UPLYSO 69 PHX# 69 paclitaxel Taxol ® 69 SomatoKine 69 HGS ETR1 mapatumumab 69 Guanilib 69 oxaliplatin Eloxatin 69 HCV protease inhibitor 69 candidate TNFerade biologic 69 Veronate R 69 Entereg TM 69 dimebon latrepirdine 69 Protease Inhibitor 69 non alcoholic steatohepatitis 69 SIMCOR 69 ELND# 69 ATL/TV# 69 alemtuzumab Campath 69 Alinia 69 2A receptor agonist 69 PROSTASCINT R 69 cromolyn sodium 69 immune modulating 69 Aurora kinase 69 CINOD 69 therapy Tovaxin 69 ularitide 69 Arimoclomol 69 nicotinic alpha 7 69 Anti Tumor 69 Cannabinor 69 therapeutic monoclonal antibody 69 ocular formulation 69 trastuzumab Herceptin R 69 BLP# Liposome Vaccine 69 alfa 2a 69 gastrointestinal stromal 69 prescribed proton pump 69 Pivotal Phase 69 HFA MDI 69 Cellegesic 69 MGCD# [001] 69 Prestara 69 dopamine D2 69 sodium thiosulfate STS 69 catheter occlusion 69 topical gel formulation 69 Rigel R# 69 Prolongs Survival 69 candidate epratuzumab 69 Tasimelteon 69 fosbretabulin 69 deforolimus 69 PGL# 69 otelixizumab 69 HEPLISAV TM 69 Epothilones 69 Bafetinib 69 mGluR5 NAM 69 #D#C# 69 Naproxcinod 69 Initiates Phase III 69 abatacept Orencia 69 BCR ABL inhibitor 69 non nucleoside HCV 69 GVAX R 69 oral antiviral 69 successfully commercialize Iluvien 69 sorafenib Nexavar 69 XL# XL# 69 small molecule chemotherapeutic 69 Ixempra 69 granted Ortec 69 Proquin XR 69 M# rationally 69 Pirfenidone 69 Announces Tentative Approval 69 tramiprosate Alzhemed TM 69 Ridaforolimus 69 class mGluR5 inhibitor 69 Immunotherapeutic 69 leading oral taxane 69 markets Gelclair R 69 dihydrochloride 69 Nexavar sorafenib 69 neuropathic pain metabolic diseases 69 incyclinide 69 Hedgehog Pathway Inhibitor 69 product platforms AZX# 69 Exelixis compounds 69 Tumour Vascular Disrupting Agent 69 sargramostim 69 novel therapeutic antibodies 69 pertuzumab 69 AzaSite Plus 69 selective antagonist 69 Prestara TM 69 See CLINICAL PHARMACOLOGY 69 Trodusquemine MSI 69 oral Factor Xa 69 novel topoisomerase 69 Neulasta R 69 Eculizumab 69 AEG# 69 PD LID 69 CINTREDEKIN BESUDOTOX 69 Phase III Clinical Trial 69 maximally tolerated dose 69 hormone LHRH antagonist 69 Dexilant 69 Clolar ® 69 Genasense ® 69 motexafin gadolinium Injection 69 Letairis ambrisentan 69 Mylan Receives Approval 69 depsipeptide 69 Solzira ™ 69 orally bioavailable mimics 69 opioid induced bowel dysfunction 69 Qutenza TM 69 LHRH antagonists 69 Anturol TM 69 Methylnaltrexone 69 Generx TM 69 6R BH4 69 ALVESCO ® 69 Novel Oral 69 Mipomersen 69 infectious diseases autoimmune diseases 69 CD# monoclonal antibody 69 Proellex TM 69 selective kinase inhibitor 69 DIFICID ™ 69 humanized anti 69 Interferon beta 69 Fluticasone 69 hypereosinophilic syndrome 69 humanized therapeutic 69 alpha folate receptor 69 Phase 1b clinical trials 69 Sevelamer 69 individualized cellular immunotherapy 69 atacicept 68 Angiocept 68 Factor Xa inhibitor 68 HuCAL PLATINUM ® CysDisplay 68 somatostatin analog 68 RNAi Therapeutic 68 DP VPA 68 Investigational Oral 68 Q#IR 68 Adenoscan R 68 Solzira TM 68 DPX Survivac 68 Eraxis 68 Prodarsan R 68 Azedra 68 novel L DOS# 68 Triapine R 68 HepeX B TM 68 Rebif ® 68 signal transduction inhibitor 68 candesartan cilexetil 68 octreotide implant 68 Curaxin CBLC# 68 Aryplase 68 Polymer Microspheres 68 CINQUIL 68 sitaxsentan 68 ORE# 68 muscarinic receptor agonist 68 humanized monoclonal antibody 68 non constipating irritable 68 BUPHENYL R 68 ABL inhibitor 68 CYCLOSET ® 68 TKM PLK1 68 huC# DM4 68 BCG refractory carcinoma 68 Cloretazine VNP#M 68 MNTX 68 Cimzia certolizumab pegol 68 intravesical infusion therapy 68 anti CD3 monoclonal 68 selective inhibition 68 Fibrillex TM 68 CCX# B 68 Vidaza R 68 cetuximab Erbitux R 68 Angiotensin Converting Enzyme 68 Aeolus Pharmaceuticals Announces 68 Achieves Primary Endpoint 68 JAK2 inhibitor 68 agent VDA 68 therefore therapeutically equivalent 68 cysteamine bitartrate 68 sulfonylhydrazine class 68 SPL# Gel vaginal microbicide 68 Vicriviroc 68 SILENOR 68 QNEXA 68 toenail onychomycosis 68 Enkephalin 68 Soliris eculizumab 68 Zemiva ™ 68 include Phenoptin TM 68 generation Hsp# inhibitor 68 ® pioglitazone HCl 68 Boceprevir 68 torsemide ER 68 Combination REOLYSIN R 68 MyVax R 68 GATTEX TM 68 TYGACIL 68 Albugon 68 Receives Approvable Letter 68 developing Zerenex ferric 68 nilotinib Tasigna ® 68 STELARA TM 68 Seliciclib 68 HCV polymerase inhibitors 68 phenylalanine ammonia lyase 68 Kuvan TM sapropterin 68 defensin mimetic antibiotic 68 immunotherapeutic agent 68 Symadex 68 sulfonylurea glimepiride 68 Zenpep 68 investigational hepatitis C 68 cinacalcet HCl 68 Allovectin 7 68 Darinaparsin 68 Benazepril 68 MCSP respectively 68 Oral Fingolimod 68 baminercept 68 Ambrisentan 68 Perifosine 68 drug GAP #B# 68 oral rivaroxaban 68 ALTROPANE R 68 proprietary intravenous formulation 68 Phase 2a Trial 68 Friedreich Ataxia FRDA 68 AEGR 68 novel nucleoside analog 68 entinostat 68 Cimzia TM 68 plus prednisone prednisolone 68 Chemokine Receptor 68 cholesteryl ester transfer 68 POSIDUR TM ELADUR TM 68 orally inhaled migraine 68 AKT inhibitor 68 ANYARA 68 CIMZIA TM 68 TACI Ig 68 Degarelix 68 Wafer polifeprosan 68 Nektar proprietary 68 pregabalin Lyrica 68 non peptidic protease 68 Angiolix 68 topical antifungal product 68 PS# [001] 68 Oral NKTR 68 novel DACH platinum 68 Aganocide ® 68 Receives Fast Track 68 Frova ® 68 milnacipran HCl 68 acetylgalactosamine 6 68 hypoxia selective 68 oxymorphone ER 68 treat male hypogonadism 68 Elacytarabine 68 vascular disrupting agents 68 CDK inhibitor 68 Lenocta TM 68 ruxolitinib 68 Phase 2b clinical trials 68 gefitinib Iressa 68 Shigamabs ® 68 SUPPRELIN R LA 68 Files Investigational 68 JAK inhibitors 68 Zoraxel 68 BrachySil TM 68 Ostarine ™ 68 Pruvel ™ 68 Fast Track Status 68 Resten NG 68 Irinotecan 68 Interferon beta 1a 68 hoFH 68 Hormone Refractory Prostate Cancer 68 Vidaza ® 68 LUNESTA ® 68 compound PMX # 68 5 FU capecitabine 68 HCl PEPCID ® famotidine 68 esomeprazole Nexium 68 Lixivaptan 68 mGluR2 positive 68 ropinirole Requip 68 Melphalan 68 combines bupropion 68 NU# direct 68 mapatumumab 68 modulator SERM 68 Ceflatonin ® 68 OXi# 68 Fortical R 68 Amplimexon 68 luteinizing hormone releasing 68 N acetylgalactosamine 6 68 HCV protease 68 candidate ridaforolimus 68 R memantine HCl 68 novel immunomodulatory 68 Sphingomab TM 68 bevacizumab Avastin ® 68 angiotensin receptor blocker ARB 68 topoisomerase II inhibitor 68 Familial Adenomatous Polyposis FAP 68 DPP4 inhibitor 68 GAMMAGARD 68 Harbor BioSciences 68 Preclinical Data 68 Cardio Vascu Grow 68 Locteron ® 68 FDA APPROVES 68 Pyridorin 68 novel prodrug 68 Saizen ® 68 Pimavanserin 68 Bicalutamide 68 Allovectin 7 R 68 selective inverse agonist 68 endothelin antagonist 68 oral talactoferrin 68 ONCONASE R 68 efaproxiral 68 subsidiaries visit http:/www.apricusbio.com 68 indinavir Crixivan 68 vorinostat 68 chronic eosinophilic leukemia 68 Begins Dosing 68 vinorelbine tartrate 68 R MSCRAMM 68 acadesine 68 Alocrest 68 Loxapine 68 EOquin TM 68 Virulizin ® 68 Dose Ranging Study 68 ILUVIEN ® 68 acetylcholinesterase inhibitor 68 Exelixis XL# 68 LibiGel transdermal testosterone gel 68 Tovaxin TM 68 Patient Enrollment 68 Bosutinib 68 Glatiramer Acetate 68 talactoferrin 68 Hydrochlorothiazide Tablets 68 Abstract Accepted 68 ixabepilone 68 alvimopan 68 investigational oral inhibitor 68 Intravenous Human 68 MAP# 68 interferon beta 1a infertility 68 FDA Accepts 68 EnzymeRx 68 ulimorelin 68 Hycamtin ® 68 TO AVOID PREGNANCY WHILE 68 Pyridorin TM 68 tenofovir disoproxil fumarate Viread 68 ALGRX 68 thromboxane A2 68 castrate resistant prostate cancer 68 HGS ETR2 68 zonisamide SR 68 Delta opioid receptor 68 MAXY G# 68 VIVITROL ® 68 Budesonide foam crofelemer 68 BZL# 68 TORISEL TM 68 rheumatoid arthritis psoriatic arthritis 68 partial agonist 68 Selective Electrochemical Tumor Ablation 68 Shows Statistically Significant 68 metformin sulfonylureas 68 GMX# 68 Aurexis 68 TNFerade ™ 68 IV APAP